Stock Screener · Library
Kezar Life Sciences, Inc. financial statement history
Source-linked financial facts for Kezar Life Sciences, Inc. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 217933000 | USD | 2023-03-14 | 2022 / FY | us-gaap:Assets | 10-K · 0000950170-23-007871 |
| As of 2022-12-31 | 299568000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Assets | 10-K · 0000950170-24-031494 |
| As of 2023-12-31 | 221235000 | USD | 2025-03-25 | 2024 / FY | us-gaap:Assets | 10-K · 0001645666-25-000010 |
| As of 2024-12-31 | 144682000 | USD | 2026-03-27 | 2025 / FY | us-gaap:Assets | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 76647000 | USD | 2026-03-27 | 2025 / FY | us-gaap:Assets | 10-K · 0001628280-26-021737 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 211654000 | USD | 2023-03-14 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-23-007871 |
| As of 2022-12-31 | 285722000 | USD | 2024-03-14 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-24-031494 |
| As of 2023-12-31 | 206950000 | USD | 2025-03-25 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001645666-25-000010 |
| As of 2024-12-31 | 137488000 | USD | 2026-03-27 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 75732000 | USD | 2026-03-27 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001628280-26-021737 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 62882000 | USD | 2023-03-14 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-23-007871 |
| As of 2022-12-31 | 40456000 | USD | 2024-03-14 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-24-031494 |
| As of 2023-12-31 | 35493000 | USD | 2025-03-25 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001645666-25-000010 |
| As of 2024-12-31 | 41749000 | USD | 2026-03-27 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 71878000 | USD | 2026-03-27 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001628280-26-021737 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 3283000 | USD | 2023-03-14 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-23-007871 |
| As of 2022-12-31 | 3431000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-24-031494 |
| As of 2023-12-31 | 3912000 | USD | 2025-03-25 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001645666-25-000010 |
| As of 2024-12-31 | 2893000 | USD | 2026-03-27 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 166000 | USD | 2026-03-27 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001628280-26-021737 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 21057000 | USD | 2023-03-14 | 2022 / FY | us-gaap:Liabilities | 10-K · 0000950170-23-007871 |
| As of 2022-12-31 | 29696000 | USD | 2024-03-14 | 2023 / FY | us-gaap:Liabilities | 10-K · 0000950170-24-031494 |
| As of 2023-12-31 | 33665000 | USD | 2025-03-25 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001645666-25-000010 |
| As of 2024-12-31 | 27766000 | USD | 2026-03-27 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 6574000 | USD | 2026-03-27 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001628280-26-021737 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 8212000 | USD | 2023-03-14 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-23-007871 |
| As of 2022-12-31 | 10997000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-24-031494 |
| As of 2023-12-31 | 17744000 | USD | 2025-03-25 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001645666-25-000010 |
| As of 2024-12-31 | 20329000 | USD | 2026-03-27 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 6574000 | USD | 2026-03-27 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001628280-26-021737 |
Long-term debt
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 9622000 | USD | 2023-03-14 | 2022 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0000950170-23-007871 |
| As of 2022-12-31 | 9834000 | USD | 2024-03-14 | 2023 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0000950170-24-031494 |
| As of 2023-12-31 | 10069000 | USD | 2025-03-25 | 2024 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001645666-25-000010 |
| As of 2024-12-31 | 5111000 | USD | 2026-03-27 | 2025 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 0 | USD | 2026-03-27 | 2025 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001628280-26-021737 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 196876000 | USD | 2025-03-25 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001645666-25-000010 |
| As of 2022-12-31 | 269872000 | USD | 2026-03-27 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001628280-26-021737 |
| As of 2023-12-31 | 187570000 | USD | 2026-03-27 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001628280-26-021737 |
| As of 2024-12-31 | 116916000 | USD | 2026-03-27 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001628280-26-021737 |
| As of 2025-12-31 | 70073000 | USD | 2026-03-27 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001628280-26-021737 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 0 | USD | 2024-03-14 | 2023 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0000950170-24-031494 |
| 2022-01-01 to 2022-12-31 | 0 | USD | 2025-03-25 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001645666-25-000010 |
| 2023-01-01 to 2023-12-31 | 7000000 | USD | 2026-03-27 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001628280-26-021737 |
| 2024-01-01 to 2024-12-31 | 0 | USD | 2026-03-27 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001628280-26-021737 |
| 2025-01-01 to 2025-12-31 | 0 | USD | 2026-03-27 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001628280-26-021737 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 38935000 | USD | 2024-03-14 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-24-031494 |
| 2022-01-01 to 2022-12-31 | 51009000 | USD | 2025-03-25 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001645666-25-000010 |
| 2023-01-01 to 2023-12-31 | 85697000 | USD | 2026-03-27 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001628280-26-021737 |
| 2024-01-01 to 2024-12-31 | 65742000 | USD | 2026-03-27 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001628280-26-021737 |
| 2025-01-01 to 2025-12-31 | 33756000 | USD | 2026-03-27 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001628280-26-021737 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -54659000 | USD | 2024-03-14 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-24-031494 |
| 2022-01-01 to 2022-12-31 | -71162000 | USD | 2025-03-25 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001645666-25-000010 |
| 2023-01-01 to 2023-12-31 | -111424000 | USD | 2026-03-27 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001628280-26-021737 |
| 2024-01-01 to 2024-12-31 | -90605000 | USD | 2026-03-27 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001628280-26-021737 |
| 2025-01-01 to 2025-12-31 | -59107000 | USD | 2026-03-27 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001628280-26-021737 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -54630000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-24-031494 |
| 2022-01-01 to 2022-12-31 | -68239000 | USD | 2025-03-25 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001645666-25-000010 |
| 2023-01-01 to 2023-12-31 | -101870000 | USD | 2026-03-27 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001628280-26-021737 |
| 2024-01-01 to 2024-12-31 | -83736000 | USD | 2026-03-27 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001628280-26-021737 |
| 2025-01-01 to 2025-12-31 | -56033000 | USD | 2026-03-27 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001628280-26-021737 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -1.04 | USD/shares | 2024-03-14 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-24-031494 |
| 2022-01-01 to 2022-12-31 | -10.13 | USD/shares | 2025-03-25 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001645666-25-000010 |
| 2023-01-01 to 2023-12-31 | -14.04 | USD/shares | 2026-03-27 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001628280-26-021737 |
| 2024-01-01 to 2024-12-31 | -11.49 | USD/shares | 2026-03-27 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001628280-26-021737 |
| 2025-01-01 to 2025-12-31 | -7.66 | USD/shares | 2026-03-27 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001628280-26-021737 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -42437000 | USD | 2024-03-14 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-24-031494 |
| 2022-01-01 to 2022-12-31 | -58846000 | USD | 2025-03-25 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001645666-25-000010 |
| 2023-01-01 to 2023-12-31 | -81645000 | USD | 2026-03-27 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001628280-26-021737 |
| 2024-01-01 to 2024-12-31 | -74212000 | USD | 2026-03-27 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001628280-26-021737 |
| 2025-01-01 to 2025-12-31 | -51777000 | USD | 2026-03-27 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001628280-26-021737 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 316000 | USD | 2024-03-14 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-24-031494 |
| 2022-01-01 to 2022-12-31 | 1578000 | USD | 2025-03-25 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001645666-25-000010 |
| 2023-01-01 to 2023-12-31 | 1810000 | USD | 2026-03-27 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001628280-26-021737 |
| 2024-01-01 to 2024-12-31 | 29000 | USD | 2026-03-27 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001628280-26-021737 |
| 2025-01-01 to 2025-12-31 | 8000 | USD | 2026-03-27 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001628280-26-021737 |
Dividends paid
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 0 | USD | 2022-03-17 | 2021 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0000950170-22-004085 |
| 2022-01-01 to 2022-12-31 | 0 | USD | 2023-03-14 | 2022 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0000950170-23-007871 |
| 2023-01-01 to 2023-12-31 | 0 | USD | 2024-03-14 | 2023 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0000950170-24-031494 |
| 2024-01-01 to 2024-12-31 | 0 | USD | 2025-03-25 | 2024 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0001645666-25-000010 |
| 2025-01-01 to 2025-12-31 | 0 | USD | 2026-03-27 | 2025 / FY | us-gaap:PaymentsOfDividendsCommonStock | 10-K · 0001628280-26-021737 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1645666
- Ticker in native snapshot
- KZR
- Reported numeric facts
- 80
- Units present
- USD · USD/shares